Evidence map›Paper›PMID 22570365›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2012

Cerebral myogenic reactivity and blood flow in type 2 diabetic rats: role of peroxynitrite in hypoxia-mediated loss of myogenic tone.

Aisha I Kelly-Cobbs, Roshini Prakash, Maha Coucha, Robert A Knight, Weiguo Li, Safia N Ogbi, Maribeth Johnson, Adviye Ergul

Open access · greenAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Cerebral multi-autoregulation model based enhanced external counterpulsation treatment planning for cerebral ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  6. Review
  7. Article
  8. Telmisartan prevents high-fat diet-induced neurovascular impairments and reduces anxiety-like behavior.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. TLR2 knockout protects against diabetes-mediated changes in cerebral perfusion and cognitive deficits.American journal of physiology. Regulatory, integrative and comparative physiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Aisha I Kelly-CobbsCharlie Norwood Veterans Administration Medical Center, Augusta, GA, USA.
Roshini Prakash
Maha Coucha
Robert A Knight
Weiguo Li
Safia N Ogbi
Maribeth Johnson
Adviye Ergul
University of Georgia · USCharlie Norwood VA Medical Center · US

Funding

Cerebrovascular mechanisms of ischemic injury in diabetesR03NS054688 · NINDS · AUGUSTA UNIVERSITY · PI ERGUL, ADVIYE · 2007 to 2008
$147k
Mechanisms of Diabetes-Mediated Cerebrovascular Injury in Ischemic StrokeF31NS066746 · NINDS · AUGUSTA UNIVERSITY · PI KELLY-COBBS, AISHA IMANI · 2010 to 2011
$51k
Cerebral Arteriole Structure/Function in Diabetic Ischemic Brain InjuryI01BX000347 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI ERGUL, ADVIYE · 2009 to 2025
–
BLRD VA I01 BX000347NINDS NIH HHS F31 NS066746NINDS NIH HHS F31-NS066746NINDS NIH HHS NS054688NINDS NIH HHS R03 NS054688
6 · The paper itself

Abstract

Dysregulation of cerebral vascular function and, ultimately, cerebral blood flow (CBF) may contribute to complications such as stroke and cognitive decline in diabetes. We hypothesized that 1) diabetes-mediated neurovascular and myogenic dysfunction impairs CBF and 2) under hypoxic conditions, cerebral vessels from diabetic rats lose myogenic properties because of peroxynitrite (ONOO(-))-mediated nitration of vascular smooth muscle (VSM) actin. Functional hyperemia, the ability of blood vessels to dilate upon neuronal stimulation, and myogenic tone of isolated middle cerebral arteries (MCAs) were assessed as indices of neurovascular and myogenic function, respectively, in 10- to 12-week control and type 2 diabetic Goto-Kakizaki rats. In addition, myogenic behavior of MCAs, nitrotyrosine (NY) levels, and VSM actin content were measured under normoxic and hypoxic [oxygen glucose deprivation (OGD)] conditions with and without the ONOO(-) decomposition catalyst 5,10,15,20-tetrakis(4-sulfonatophenyl) prophyrinato iron (III), chloride (FeTPPs). The percentage of myogenic tone was higher in diabetes, and forced dilation occurred at higher pressures. Functional hyperemia was impaired. Consistent with these findings, baseline CBF was lower in diabetes. OGD reduced the percentage of myogenic tone in both groups, and FeTPPs restored it only in diabetes. OGD increased VSM NY in both groups, and although FeTPPs restored basal levels, it did not correct the reduced filamentous/globular (F/G) actin ratio. Acute alterations in VSM ONOO(-) levels may contribute to hypoxic myogenic dysfunction, but this cannot be solely explained by the decreased F/G actin ratio due to actin nitration, and mechanisms may differ between control and diabetic animals. Our findings also demonstrate that diabetes alters the ability of cerebral vessels to regulate CBF under basal and hypoxic conditions.

Indexed as

ActinsAnimalsCell HypoxiaCerebrovascular CirculationDiabetes Mellitus, Type 2Disease Models, AnimalHyperemiaMaleMetalloporphyrinsMiddle Cerebral ArteryMuscle, Smooth, VascularPeroxynitrous AcidRatsRats, WistarTyrosine3-nitrotyrosine5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chlorideActinsMetalloporphyrinsPeroxynitrous AcidTyrosine

Identifiers

PMID22570365
PMCPMC3400801
OpenAlexW2166890974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.